Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Xiaolong Miao, Zelai Wu, Yuancong Jiang, Han Liu & Weihua Gong. (2022) An efficient combination immunotherapy for antitumor immunity without accelerating cardiac allograft rejection. Immunology 169:2, pages 157-166.
Crossref
Crossref
Emiko TakahashiHiroshi ImaiYuta TsuyukiNatsuki TaniguchiYasunori KogureKeisuke KataokaTakashi TsuchidaSatoshi BabaToyonori TsuzukiTakatoshi ShimauchiShigeo Nakamura. (2023) Enhanced PD-L1 expression on tumor cells in primary CD30-positive cutaneous large T-cell lymphoma: a report of lymph node lesions of four cases. Journal of Clinical and Experimental Hematopathology 63:1, pages 49-57.
Crossref
Crossref
N. Y. Samaneva, I. B. Lysenko, N. V. Nikolaeva, E. A. Kapuza, I. A. Kamaeva, Y. S. Gaysultanova, A. V. Tishina & T. F. Pushkareva. (2022) EVOLUTION OF DRUG THERAPY FOR CLASSICAL HODGKIN LYMPHOMA. South Russian Journal of Cancer 3:3, pages 41-47.
Crossref
Crossref
Tasuku Kawano, Yuta Tsuyuki, Yuka Suzuki, Kazuyuki Shimada, Seiichi Kato, Taishi Takahara, Mayuko Mori, Masato Nakaguro, Ayako Sakakibara, Shigeo Nakamura & Akira Satou. (2021) Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma. American Journal of Surgical Pathology 45:12, pages 1606-1615.
Crossref
Crossref
Akira Satou & Shigeo Nakamura. (2021) EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency. Cancer Medicine 10:19, pages 6777-6785.
Crossref
Crossref
Yalda Amiri Hezave, Zohreh Sharifi, Fahime Ranjbar kermani & Majide Shahabi. (2021) The association of polymorphisms (rs2227981 and rs10204525) of PDCD1 gene with susceptibility to human T-cell leukemia virus type 1. Microbial Pathogenesis 158, pages 105049.
Crossref
Crossref
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti‐Violetti & Emilio Berti. (2021) CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver. European Journal of Immunology 51:7, pages 1660-1671.
Crossref
Crossref
F Li, Y Chen, M Pang, P Yang & H Jing. (2021) Immune checkpoint inhibitors and cellular treatment for lymphoma immunotherapy. Clinical and Experimental Immunology 205:1, pages 1-11.
Crossref
Crossref
Laura Jimbu, Oana Mesaros, Cristian Popescu, Alexandra Neaga, Iulia Berceanu, Delia Dima, Mihaela Gaman & Mihnea Zdrenghea. (2021) Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?. Pharmaceuticals 14:4, pages 288.
Crossref
Crossref
Ayako SakakibaraKei KohnoEri IshikawaYuka SuzukiYuta TsuyukiSatoko ShimadaKazuyuki ShimadaAkira SatouTaishi TakaharaAkiko OhashiEmiko TakahashiSeiichi KatoShigeo NakamuraNaoko Asano. (2021) Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review. Journal of Clinical and Experimental Hematopathology 61:4, pages 182-191.
Crossref
Crossref
Kanae Okada, Taishi Takahara, Yuka Suzuki, Kei Kohno, Ayako Sakakibara, Akira Satou, Emiko Takahashi & Shigeo Nakamura. (2020) Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD‐L1 expression. Pathology International 71:1, pages 24-32.
Crossref
Crossref
Emiko Takahashi, Takashi Tsuchida, Satoshi Baba, Toyonori Tsuzuki, Takatoshi Shimauchi, Yoshiki Tokura, Yasuhiko Tamada & Shigeo Nakamura. (2020) Enhanced PD‐L1 expression on tumor cells in primary cutaneous large T‐cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases. Pathology International 70:10, pages 804-811.
Crossref
Crossref
Rana Mhaidly, Adrien Krug, Philippe Gaulard, François Lemonnier, Jean-Ehrland Ricci & Els Verhoeyen. (2020) New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP. Oncogenesis 9:8.
Crossref
Crossref
Samuel Okurut, David R. Boulware, Joseph Olobo & David B. Meya. (2020)
Landmark clinical observations and immunopathogenesis pathways linked to HIV and
Cryptococcus
fatal central nervous system co‐infection
. Mycoses 63:8, pages 840-853.
Crossref
Crossref
Yuka Suzuki, Kei Kohno, Kosei Matsue, Ayako Sakakibara, Eri Ishikawa, Satoko Shimada, Kazuyuki Shimada, Seiyo Mabuchi, Taishi Takahara, Seiichi Kato, Shigeo Nakamura & Akira Satou. (2020) PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy. Cancer Medicine 9:13, pages 4768-4776.
Crossref
Crossref
Massimo Giuliani & Alessandro Poggi. (2020) Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies. Cells 9:7, pages 1578.
Crossref
Crossref
Sonja Althammer, Tze Heng Tan, Andreas Spitzmüller, Lorenz Rognoni, Tobias Wiestler, Thomas Herz, Moritz Widmaier, Marlon C. Rebelatto, Helene Kaplon, Diane Damotte, Marco Alifano, Scott A. Hammond, Marie-Caroline Dieu-Nosjean, Koustubh Ranade, Guenter Schmidt, Brandon W. Higgs & Keith E. Steele. (2019) Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Ayako Sakakibara, Yuichiro Inagaki, Eiki Imaoka, Yu Sakai, Masafumi Ito, Eri Ishikawa, Satoko Shimada, Kazuyuki Shimada, Yuka Suzuki, Shigeo Nakamura, Akira Satou & Kei Kohno. (2019) Divergence and heterogeneity of neoplastic PD‐L1 expression: Two autopsy case reports of intravascular large B‐cell lymphoma. Pathology International 69:3, pages 148-154.
Crossref
Crossref
Ravnit‐Kaur Grewal, Manogari Chetty, Emmanuel‐Akinola Abayomi, Ciprian Tomuleasa & Jonathan R. Fromm. (2018) Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma. Cytometry Part B: Clinical Cytometry 96:2, pages 116-127.
Crossref
Crossref
Yuka Suzuki, Ayako Sakakibara, Kazuyuki Shimada, Satoko Shimada, Eri Ishikawa, Shigeo Nakamura, Seiichi Kato, Taishi Takahara, Naoko Asano, Akira Satou & Kei Kohno. (2019) Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma. Pathology International 69:1, pages 13-20.
Crossref
Crossref
Aksinija A. Kogan, Rena G. Lapidus, Maria R. Baer & Feyruz V. Rassool. 2019. Cancer Stem Cells. Cancer Stem Cells
213
253
.
Monika HerrmannChristina KrupkaKatrin DeiserBettina BrauchleAnetta MarcinekAna Ogrinc WagnerFelicitas RatajRalph MocikatKlaus H. Metzeler, Karsten Spiekermann, Sebastian KoboldNadja C. FennKarl-Peter HopfnerMarion Subklewe. (2018) Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia. Blood 132:23, pages 2484-2494.
Crossref
Crossref
Margarita Kirienko, Martina Sollini & Arturo Chiti. (2018) Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy. Clinical and Translational Imaging 6:6, pages 417-427.
Crossref
Crossref
Amro Mohamed Sedky El-Ghammaz, Hoda Ahmed Gadallah, Gihan Kamal, Mohammed Magdy Maher & Mohamad Ayed Mohamad. (2018) Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients. Clinical and Experimental Medicine 18:4, pages 505-512.
Crossref
Crossref
Ayako Sakakibara, Emiko Takahashi, Eri Ishikawa, Kei Kohno, Naoko Asano & Shigeo Nakamura. (2018) Neoplastic PD-L1 expression on interdigitating dendritic cell sarcoma: A supplementary study of a case report. Pathology International 68:10, pages 577-578.
Crossref
Crossref
Ziwei Liao, Xuewen Lv, Sichu Liu, Zifan He, Shaohua Chen, Liang Wang, Wenyu Li & Yangqiu Li. (2018) Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK/T-CL. Asia-Pacific Journal of Clinical Oncology 14:5, pages e252-e258.
Crossref
Crossref
Ayako Sakakibara, Kei Kohno, Ahmed E Eladl, Teerada Klaisuwan, Eri Ishikawa, Yuka Suzuki, Satoko Shimada, Masato Nakaguro, Yoshie Shimoyama, Taishi Takahara, Seiichi Kato, Naoko Asano, Shigeo Nakamura & Akira Satou. (2018) Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells. Histopathology 72:7, pages 1156-1163.
Crossref
Crossref
Christiane Thallinger, Thorsten Füreder, Matthias Preusser, Gerwin Heller, Leonhard Müllauer, Christoph Höller, Helmut Prosch, Natalija Frank, Rafal Swierzewski, Walter Berger, Ulrich Jäger & Christoph Zielinski. (2017) Review of cancer treatment with immune checkpoint inhibitors. Wiener klinische Wochenschrift 130:3-4, pages 85-91.
Crossref
Crossref
Ayako SakakibaraYuichiro InagakiEiki ImaokaEri IshikawaSatoko ShimadaKazuyuki ShimadaYuka SuzukiShigeo NakamuraAkira Satou & Kei Kohno. (2018) Autopsy case report of intravascular large B-cell lymphoma with neoplastic PD-L1 expression. Journal of Clinical and Experimental Hematopathology 58:1, pages 32-35.
Crossref
Crossref
Shaji K. Kumar, Vincent Rajkumar, Robert A. Kyle, Mark van Duin, Pieter Sonneveld, María-Victoria Mateos, Francesca Gay & Kenneth C. Anderson. (2017) Multiple myeloma. Nature Reviews Disease Primers 3:1.
Crossref
Crossref